Quantcast
Home > Quotes > NEO
NEO

NeoGenomics, Inc. Common Stock (NEO) Quote & Summary Data

$20.17
*  
0.19
0.95%
Get NEO Alerts
*Delayed - data as of Apr. 23, 2019  -  Find a broker to begin trading NEO now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    NEO Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
22
Today's High / Low
$ 20.49 / $ 19.76
Share Volume
681,852
50 Day Avg. Daily Volume
828,077
Previous Close
$ 19.98
52 Week High / Low
$ 22.17 / $ 9.27
Market Cap
1,907,393,073
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.78

Intraday Chart

Shares Traded

Share Volume:
681,852
50 Day Avg. Daily Volume:
828,077

P/E Ratio

P/E Ratio:
336.17
Forward P/E (1y):
112.06
Earnings Per Share (EPS):
$ 0.06

Trading Range

The current last sale of $20.17 is 117.58% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 20.49 $ 22.17
 Low: $ 19.76 $ 9.27

ETFs with NEO as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
1.64% Invesco S&P Smallcap 600 Pure Growth ETF (RZG) -1.24 (-1.06%)
1.25% Invesco Russell 2000 Pure Growth ETF (PXSG) +3.32 (9.82%)
0.43% iShares Microcap ETF (IWC) +1.81 (1.95%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

NeoGenomics, Inc., a Nevada corporation (referred to individually as the "Parent Company" or collectively with its subsidiaries as "NeoGenomics", "we", "us", "our" or the "Company" in this Annual Report) is the registrant for SEC reporting purposes. Our common stock is listed on the NASDAQ Capital Market under the symbol "NEO". Overview We operate a network of cancer-focused genetic testing laboratories in the United States as well as a laboratories in Switzerland and Singapore. Our mission is to improve patient care through exceptional genetic and molecular testing services. Our vision is to become the World's leading cancer testing and information company by delivering uncompromising quality, exceptional service and innovative solutions. As of December 31, 2018, the Company has laboratory locations in Ft.  ... More ...  



Risk Grade

Where does NEO fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 19.97
Open Date:
Apr. 23, 2019
Close Price:
$ 20.17
Close Date:
Apr. 23, 2019


Consensus Recommendation

Analyst Info